** = Publications listed in SCI/SSCI/Pubmed
** Grosspoetzl, M; Riedl, R; Schliessleder, G; Hu, ZJ; Michaelides, M; Sadda, S; Birch, D; Issa, PC; Wedrich, A; Seidel, G; Scholl, HPN; Strauss, RW
The Progression of PROM1-associated retinal degeneration as determined by spectral-domain optical coherence tomography over a 24-months period.
Am J Ophthalmol. 2023;
Doi: 10.1016/j.ajo.2023.11.010
Web of Science
PubMed
FullText
FullText_MUG
** Schließleder, G; Kalitzeos, A; Kasilian, M; Singh, N; Wang, Z; Hu, Z; Großpötzl, M; Sadda, S; Wedrich, A; Michaelides, M; Strauss, RW
Deep phenotyping of PROM1-associated retinal degeneration.
Br J Ophthalmol. 2023;
Doi: 10.1136/bjo-2022-322036
Web of Science
PubMed
FullText
FullText_MUG
** Pahljina, C; Sarny, S; Hoeflechner, L; Falb, T; Schliessleder, G; Lindner, M; Ivastinovic, D; Mansouri, K; Lindner, E
Glaucoma Medication and Quality of Life after Phacoemulsification Combined with a Xen Gel Stent.
J Clin Med. 2022; 11(12):
Doi: 10.3390/jcm11123450
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Werkl, P; Woltsche, N; Silbernagel, B; Schließleder, G; List, W; Steinwender, G; Boldin, I; Horwath-Winter, J
[New treatments present new challenges : Ocular side effects of belantamab mafodotin].
Ophthalmologie. 2022; 119(7):730-732
Doi: 10.1007/s00347-021-01408-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG